Harrow Price Target Raised to $26.00/Share From $24.00 by Craig-Hallum

Harrow Price Target Raised to $26.00/Share From $24.00 by Craig-Hallum

Dow Jones13:02

Harrow Is Maintained at Buy by Craig-Hallum

Harrow Is Maintained at Buy by Craig-Hallum

Dow Jones13:02

B. Riley Securities Reiterates Buy on Harrow, Raises Price Target to $29

B. Riley Securities analyst Sahil Kazmi reiterates Harrow with a Buy and raises the price target from $26 to $29.

Analyst UpgradesMay 15 09:11

Harrow Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 69.59% B. Riley Securities $26 → $29 Reiterates Buy → Buy 04/11/2024 40.35% Craig-Hallum → $24

BenzingaMay 15 09:09

Harrow to Present at Two Investor Conferences in May

NASHVILLE, Tenn.--(BUSINESS WIRE)--$HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following two investor

BusinesswireMay 15 06:00

Harrow Inc (HROW) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Advances

Yahoo FinanceMay 15 02:00